Hepatic Resection Provides Survival Benefit for Selected Intermediate-Stage (BCLC-B) Hepatocellular Carcinoma Patients.
Cancer Res Treat
; 51(1): 65-72, 2019 Jan.
Article
in En
| MEDLINE
| ID: mdl-29510616
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Hepatocellular
/
Liver Neoplasms
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Female
/
Humans
/
Male
Language:
En
Journal:
Cancer Res Treat
Year:
2019
Document type:
Article
Affiliation country:
China
Country of publication: